Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Dose Escalation of ArtemiCoffee in Patients With Advanced Ovarian Cancer

NCT04805333 is registered in ClinicalTrials.gov with Frederick R. Ueland, M.D. as lead sponsor.

NCT NCT04805333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04805333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Dose Escalation of ArtemiCoffee in Patients With Advanced Ovarian Cancer
Lead sponsor
Frederick R. Ueland, M.D.
Phase
Phase 1
Overall status
Completed
Start date
March 26, 2021
Completion date
February 4, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer